NaMi Diagnostics
PrivateLast Round
Accelerator
Dec 22, 2023
Total Funding Raised
$249,079
Company Overview
NaMi Diagnostics operates in Healthcare & Life Sciences and is based in Lubbock, Texas. Its latest recorded funding round was an Accelerator round in December 2023.
NaMi Diagnostics is a biotechnology company developing rapid, cell-based diagnostic platforms for the early detection of sepsis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NaMi Diagnostics Comparables
Compare NaMi Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Immunexpress | 85% | |
| Novus Diagnostics | 82% | |
| Inflammatix | 80% |
For institutional investors. Book with your work email.
NaMi Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Dec 22, 2023 | ||||
| Grant | Jan 1, 2023 |
For institutional investors. Book with your work email.
NaMi Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Texas Tech Accelerator | Accelerator |
| NIH RADx | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 22, 2023
$25K round from Texas Tech Accelerator
For institutional investors. Book with your work email.
NaMi Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NaMi Diagnostics's valuation, stock price, and market status.
Is NaMi Diagnostics a public or private company?
NaMi Diagnostics is a private company.
What is the current stock price of NaMi Diagnostics?
NaMi Diagnostics is a private company, so its shares have no public market price. Caplight tracks NaMi Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NaMi Diagnostics worth (valuation)?
Valuation information for NaMi Diagnostics is not publicly available.
Can I buy NaMi Diagnostics stock?
NaMi Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NaMi Diagnostics's last funding round?
NaMi Diagnostics's most recent funding round was Accelerator on December 22, 2023.
Who are the main investors in NaMi Diagnostics?
Key investors in NaMi Diagnostics include Texas Tech Accelerator, NIH RADx.
Will NaMi Diagnostics IPO soon?
No public IPO plans have been announced for NaMi Diagnostics.
How can I track NaMi Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in NaMi Diagnostics's shares on secondary markets.